Literature DB >> 10847793

No association between the APOE epsilon4 allele and outcome and susceptibility in primary progressive multiple sclerosis.

S J Weatherby, C L Mann, A A Fryer, R C Strange, C P Hawkins, V L Stevenson, S M Leary, A J Thompson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10847793      PMCID： PMC1736883          DOI： 10.1136/jnnp.68.4.532

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  5 in total

Review 1.  Multiple sclerosis in the elderly patient.

Authors:  Amer Awad; Olaf Stüve
Journal:  Drugs Aging       Date:  2010-04-01       Impact factor: 3.923

2.  Association of polymorphisms in the apolipoprotein E region with susceptibility to and progression of multiple sclerosis.

Authors:  Silke Schmidt; Lisa F Barcellos; Karen DeSombre; Jacqueline B Rimmler; Robin R Lincoln; Patricia Bucher; Ann M Saunders; Eric Lai; Eden R Martin; Jeffery M Vance; Jorge R Oksenberg; Stephen L Hauser; Margaret A Pericak-Vance; Jonathan L Haines
Journal:  Am J Hum Genet       Date:  2002-02-11       Impact factor: 11.025

Review 3.  Aging, neurodegenerative disease, and traumatic brain injury: the role of neuroimaging.

Authors:  Carrie Esopenko; Brian Levine
Journal:  J Neurotrauma       Date:  2014-12-29       Impact factor: 5.269

4.  Detection of apolipoprotein E phenotype in unconcentrated cerebrospinal fluid.

Authors:  P D Mehta; B A Patrick; T Pirttila; P K Coyle; P S Aisen
Journal:  J Clin Lab Anal       Date:  2003       Impact factor: 2.352

5.  Association of APOE Serum Levels and APOE ε2, ε3, and ε4 Alleles with Optic Neuritis.

Authors:  Liucija Momkute; Alvita Vilkeviciute; Greta Gedvilaite; Gabriele Dubinskaite; Loresa Kriauciuniene; Rasa Liutkeviciene
Journal:  Genes (Basel)       Date:  2022-07-01       Impact factor: 4.141
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.